CymaBay Therapeutics, Inc. (0I5P.L) LSE

32.48

+0.0029(+0.01%)

Updated at March 21, 2024 04:56PM

Currency In USD

Valuation

Market Cap2.53B
Enterprise Value2.44B
P/E Ratio-32.74
PEG Ratio-0.33
Price/Sales Ratio119.98
Price/Book Ratio11.8
Enterprise/Revenue117.02
Enterprise/EBITDA-42.41

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-3.39
Operating Margin-3.27

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.64

Income Statement

Revenue31.07M
Revenue/Share0.29
Gross Profit30.39M
EBITDA-85.74M
Net Income-105.37M
Diluted EPS-0.99

Balance Sheet

Total Cash394.26M
Total Cash/Share3.71
Total Debt114.49M
Total Debt/Equity0.39
Current Ratio10.96
Book Value Per Share2.75

Price History

52-Week Change218.15
52-Week High32.48
52-Week Low32.48
Moving Average 50 Days26.99
Moving Average 200 Days17.16

Statistics

Average Volume2,721
Shares Outstanding66.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A